Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer


Accumulating preclinical evidence suggests that anticancer immune responses contribute to the success of chemotherapy. The predictive significance of tumor-infiltrating lymphocytes (TILs) for response to neoadjuvant chemotherapy in non-small cell lung cancer (NSCLC) remains unknown. The aim of this study was to investigate the prognostic and predictive… (More)
DOI: 10.1007/s00262-012-1231-7


6 Figures and Tables